May 7, 2020 / 1:05 PM / a month ago

BRIEF-Azurrx Biopharma Announces Entry Into Packaging, Labeling And Distribution Agreement With Creapharm Clinical Supplies For MS1819 Clinical Trial Drug Product

May 7 (Reuters) - AzurRx BioPharma Inc:

* AZURRX BIOPHARMA ANNOUNCES ENTRY INTO PACKAGING, LABELING AND DISTRIBUTION AGREEMENT WITH CREAPHARM CLINICAL SUPPLIES FOR MS1819 CLINICAL TRIAL DRUG PRODUCT

* AZURRX - MS1819 CLINICAL TRIAL DRUG SUPPLY WILL BE SENT DIRECTLY TO CLINICAL SITES IN U.S. AND IN EUROPE, INCLUDING, POLAND, HUNGARY, SPAIN & TURKEY Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below